SEER
Seer, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.71
−1.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.42x
- Price / sales
- 6.84x
- Price / cash flow
- -2.18x
Enterprise value
- Enterprise value
- -$35.8M
- EV / sales
- -2.58x
- EV / EBITDA
- 0.57x
- EV / EBIT
- 0.51x
- Market cap
- $94.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026